|
Market Closed -
NYSE
00:03:03 02/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 96.69 USD | -2.17% |
|
-4.33% | -22.83% |
| 09-30 | Abbott Launches Simplescreen Crc Blood Test in the U.S | CI |
| 09-30 | Abbott Launches SimpleScreen Blood Test for Colorectal Cancer | MT |
| Market Cap | 167B 149B 139B 127B 238B 16,109B 242B 1,681B 651B 8,204B 628B 615B 26,350B | P/E 2026 * |
27.4x | P/E 2027 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise Value | 191B 170B 159B 145B 273B 18,414B 276B 1,922B 744B 9,378B 718B 702B 30,121B | EV / Sales 2026 * |
3.81x | EV / Sales 2027 * | 3.45x |
| Free-Float |
86.16% | Yield 2026 * |
2.66% | Yield 2027 * | 2.83% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Xetra
| ABL | Delayed | |
|
Tradegate
| ABL | Real-time | |
|
Boerse Muenchen
| ABL | Real-time | |
|
CBOE
| Real-time | ||
|
London S.E.
| ABT | Delayed | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
CBOE
| ABT | Real-time | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | -2.17% | ||
| 1 week | -4.33% | ||
| Current month | -2.17% | ||
| 1 month | -11.24% | ||
| 3 months | +4.89% | ||
| 6 months | -5.56% | ||
| Current year | -22.83% |
| 1 week | 96.54 |  | 101.76 |
| 1 month | 96.54 | | 112 |
| Current year | 81.97 | | 129.46 |
| 1 year | 81.97 | | 135.36 |
| 3 years | 81.97 | | 141.23 |
| 5 years | 81.97 | | 142.6 |
| 10 years | 37.38 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/09/26 | Tax | Director | -52,507 | 0.0030% | ||
| 02/09/26 | Sell | Controller/Auditor | -27 | 0.0000% | ||
| 01/09/26 | Tax | Chief Financial Officer | -388 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.17% | -4.33% | -27.56% | -0.17% | 167B | |
| +0.17% | -2.34% | -8.83% | +10.31% | 111B | |
| -0.88% | +1.19% | -25.04% | -0.11% | 105B | |
| -0.69% | -0.07% | -47.78% | -12.45% | 74.82B | |
| +3.17% | -0.03% | -0.64% | +72.13% | 59.11B | |
| -1.05% | +2.75% | +13.34% | +59.17% | 51.8B | |
| -0.52% | -0.65% | -6.74% | -31.12% | 48.5B | |
| -0.85% | +0.85% | -16.51% | +18.41% | 40.79B | |
| -0.07% | -1.42% | +30.49% | -7.58% | 32.54B | |
| -2.07% | -0.86% | -11.04% | -25.49% | 30.76B | |
| Average | -0.50% | -0.26% | -10.03% | +8.31% | 72.09B | |
| Weighted average by Cap. | -0.67% | -0.95% | -15.92% | +7.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.21B 44.59B 41.7B 38B 71.55B 4,834B 72.53B 505B 195B 2,462B 189B 184B 7,907B | 54.53B 48.43B 45.29B 41.27B 77.71B 5,250B 78.77B 548B 212B 2,674B 205B 200B 8,588B |
| Net income | 6.3B 5.6B 5.24B 4.77B 8.98B 607B 9.11B 63.34B 24.52B 309B 23.67B 23.15B 993B | 7.98B 7.09B 6.63B 6.04B 11.37B 768B 11.52B 80.16B 31.03B 391B 29.95B 29.3B 1,256B |
| Net Debt | 23.94B 21.26B 19.88B 18.12B 34.11B 2,305B 34.58B 241B 93.12B 1,174B 89.88B 87.93B 3,770B | 20.96B 18.61B 17.41B 15.86B 29.86B 2,018B 30.27B 211B 81.52B 1,028B 78.68B 76.98B 3,301B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | $96.69 | -2.17% | 8,862,865 |
| 30/09/26 | $98.83 | -2.10% | 7,571,495 |
| 29/09/26 | $100.95 | -0.03% | 8,049,113 |
| 28/09/26 | $100.98 | -0.31% | 6,802,510 |
| 25/09/26 | $101.29 | +0.22% | 7,784,309 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
